Tele-TOKS: Implementation of an early warning system

Title
Tele-TOKS Implementation of an early warning system on a cardiology ward utilizing a wrist-worn medical device, with comparison to conventional measurements taken by nurses

Topic
Vital sign changes often precede cardiac arrest, unexpected death, or ICU admission. If observed and treated, it could prevent the patient's condition from deteriorating. Systematically detecting abnormal vital signs can predict which patients are at risk of death and improve outcomes through timely interventions. TOKS is a Danish algorithm derived from the UK's National Early Warning Score (NEWS). TOKS 2.1 was inspired by New Zealand's Wellington Early Warning Score, which measures vital parameters and calculates an overall score. Cardiowatch 287-1 is a wrist-worn, wireless remote monitoring device for residential and healthcare environments and is CE-certified and EU-MDR-compliant. The device continuously monitors respiratory rate, oxygen saturation, blood pressure, pulse rate, and core temperature from the wrist, as required for automated TOKS 2.1 measurements.

Number of Participants
The study will include at least 100 patients over the age of 18 who are referred to our hospital's cardiology ward.

Target points
Sensitivity and specificity of the Corsano Health Cardiowatch 287-2B wristband in comparison to manual measurements performed by trained nurses.

Study Centre
Regionshospital Nordjylland
Bispensgade 37
9800 Hjørring, Denmark

Start time, Duration
Q4 2022, 6 months

Interested in our Trial Programme?

Corsano Cardiowatch Bracelets enable continuous monitoring with multiple algorithms. Corsano is working closely with cardiologists, scientists, hospitals, patients, and research organisations.  Scientific research demonstrates the legitimacy of Cardiowatch 287 algorithms. 

We are currently performing pilots with selected clients. Contact us if you want to know more!

Corsano CardioWatch is a wrist worn medical grade multi sensor bracelet to capture up to 19 vital parameters. Primary use cases are 24/7 continuous clinical trials and remote patient monitoring.  
 
The bracelet monitor offers flexibility to set data collection intervals by minute, by second or 25Hz, 32 Hz or 128 Hz. We measure Heart Rate, RR intervals, Breathing Rate, A-Fib detection, Skin Temperature, Activity and Sleep. SpO2, Core Body Temperature, ECG and Blood Pressure are in development.  
 
Clinical accuracy is paramount for us. In addition to third parties' algorithms, i.e. from Philips, we run our proprietary algorithms to realize superior data accuracy. Corsano technology has been clinically validated in major academic hospitals. The bracelet is manufactured under ISO 13485 and CE-MDR compliance. The process for FDA Clearance has started. 
 
Our end-to-end solution consists of light-weight and comfortable bracelets with a patient research portal. We have developed and produced over 200’000 devices. The Corsano platform has been optimized on connections, data buffers and battery life up to 15 days. We offer access to raw continuous high frequency data through API and cloud-to-cloud solutions. 
 

The founders of Corsano Health have over 100 years of experience in the Swiss Watch industry, with deep experience about ergonomic design and materials for wearables that are worn 24/7.